Immunotherapy Safety and Efficacy banner

The 2nd Annual Immunotherapy Safety & Efficacy conference at PEGS Europe presents a range of emerging modalities, armed with better understanding of the tumour microenvironment and new IO-combination strategies, with promise to overcome toxicities and drug resistance, and improve clinical outcomes. Examples include: T cell engagers, checkpoint inhibitors, bispecifics, ADCs and adjuvant immunotherpy.